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In the present study, an ethanolic root-bark extract of Moringa oleifera (MO) was exam-
ined for its antiulcer potential in albino Wistar rats using two experimental models:
ethanol-induced and pylorus ligation-induced gastric ulceration. The extract was orally
administered at three different doses (150, 350, and 500 mg/kg) for 15 consecutive days.
The antiulcer effects in rats treated with different doses of the extract and omeprazole
(30 mg/kg, p.o.) were determined and compared statistically with the antiulcer effects in
the control rats treated with saline (NaCl, 0.9%). The MO at doses of 350 and 500 mg/kg
decreased the ulcer index significantly as compared to the control group (p < 0.01). The
percentage protections against gastric ulcers were 82.58%, 85.13%, and 86.15% for MO
doses of 150, 350, and 500 mg/kg, respectively, in the pylorus-ligated ulcer model and
55.75%, 59.33%, and 78.51%, respectively, in the ethanol-induced ulcer model. The MO
significantly reduced the free acidity, total acidity, and ulcer index (p < 0.01) and
increased the pH of gastric content compared with the control group. This study suggests
that MO possesses valuable antiulcer, antisecretory, and cytoprotective activity. Thus, an
ethanolic root-bark extract of Moringa oleifera can be used as source for an antiulcer




Antiulcer potential of Moringa oleifera extract 2151. Introduction
Peptic ulcer disease is the most common gastrointestinal
tract disorder and includes gastric and duodenal ulcers,
which are usually acidic and, thus, extremely painful [1].
The pathophysiology of peptic ulcer disease involves an
imbalance between offensive (acid, pepsin, and Heli-
cobacter pylori) and defensive factors (mucin, prosta-
glandin, bicarbonate, nitric oxide, and growth factors) [2].
Several factorsdsuch as improper digestion, metabolism,
and elimination of food, and mental and physical
stressdenhance the development of peptic ulcers. A
number of drugs are available for the treatment of peptic
ulcers, but the clinical evaluation of these drugs indicates
high incidences of side effects and drug interactions. These
negative effects are the rationale for the development of
new antiulcer drugs and the search for novel molecules in
plants, such as Ocimum sanctum, Azadirachta indica,
Asparagus racemosus, Musa sapientum, Centella asiatica,
Bacopa monnieri, and Bidens pilosa, that could offer better
protection and decreased relapse [3]. In the present study,
the antiulcer potential of an ethanolic extract of Moringa
oleifera root bark (MO) was studied using ethanol- and
pylorus ligation-induced gastric lesions in experimental
rats.
M. oleifera Lamm (Family: Moringaceae), also known as
the drumstick tree and horseradish tree, is indigenous to
Northwest India, Pakistan, Bangladesh, and Afghanistan [4].
This tree is the most widely cultivated species of the genus
Moringa. Leaves of M. oleifera are highly nutritious, being a
significant source of b-carotene, vitamin C, protein, iron,
and potassium [5]. Almost all parts of this plantdroot,
leaves, fruit, bark, seeds, and flowersdare reported to
have important medicinal values as cardiac and circulatory
stimulants and to have antitumor, antipyretic, anti-
inflammatory, antihypertensive, diuretic, cholesterol-
lowering, antidiabetic, antioxidant, antispasmodic, anti-
bacterial, and antifungal activities [6e11]. Moreover, the
ethanolic extract of leaves of M. oleifera is reported to
have antiulcer activity [12]. In view of the above, this study
was performed to investigate the antiulcer potential of an
ethanolic root-bark extract of M. oleifera by using ethanol-
induced gastric ulcers and pylorus ligation-induced ulcers.
2. Material and methods
2.1. Animals
Male albino rats of the Wistar strain weighing about
200e250 g were procured from the Indian Institute of
Chemical Biology, Kolkata, India. The rats were housed in
solid-bottomed polypropylene cages and kept under stan-
dard husbandry conditions. The rats were fed with standard
diet and water ad libitum. The experiments were designed
and conducted in accordance with the ethical norms
approved by the CPCSEA (Committee for the Purpose of
Control and Supervision of Experiments on Animals) and the
Institutional Animal Ethics Committee of the SLT (Sulochna
Lakhanlal Trivedi) Institute of Pharmaceutical Sciences,
Guru Ghasidas Central University, Bilaspur (994/a/GO/06/
CPCSEA, IACE/Pharmacy/2012/42).2.2. Materials
The root barks of M. oleifera were collected from the local
area of Chhattisgarh, India. The plant was taxonomically
identified and authenticated by Dr. H.B. Singh (head of the
Raw Materials and Herbarium Museum, National Institute of
Science Communication and Information Resources, New
Delhi, India). The specimens were deposited in the Phar-
macology Department of the SLT Institute of Pharmaceu-
tical Sciences, Guru Ghasidas Central University, Bilaspur
(C.G.), India. The powdered plant material was packed in
soxhlet extractor and heated under reflux using 70% ethanol
as a solvent. The percentage yield of the ethanolic extract
from the root bark of M. oleifera was found to be 11.8%.
The extract was filtered, concentrated under reduced
pressure, dried, and stored in a tightly closed container at
4 C for future use. The following chemicals and reagents
were procured: ethanol (Jiangsu Huaxi International,
China), diethyl ether (Fischer Scientific, Mumbai, India),
and omeprazole (Cipla Ltd, India). All chemicals used were
of analytical grade.
2.3. Phytochemical analysis
The MO was subjected to the following test for the phyto-
chemical screening methods [13,14]: carbohydrates were
identified by using Molisch’s test (Molish’s reagent, Organo
Biotech Laboratories Pvt. Ltd., New Delhi, India), alkaloids by
using Mayer’s test (Mayer’s reagent, Oxford Laboratory,
Maharashtra, India), and Hager’s test (Hager’s reagent, Alpha
Chemika, Mumbai, India), phenols by using a ferric chloride
test (Ferric chloride, Alpha Chemika, Mumbai, India), tannins
by using a gelatin test (Gelatin, Triveni Chemicals, Vapi, India)
and a ferric chloride test, flavonoids by using an alkaline re-
agent test (Sodiumhydroxide,AlphaChemica,Mumbai, India),
proteins and amino acids by using a xanthoproteic test (Nitric
acid, Vats International, Delhi, India) and ninhydrin test
(Ninhydrin reagent, Shinton Chemicals Pvt. Ltd., Indore,
India), cardiac glycosides by using Legal’s test (Sodium nitro-
pruside, Brisben Chemicals, Mumbai, India), and saponins by
using a foam test.
The acute oral toxicity study was performed as per the
OECD (Organisation for Economic Co-operation and Devel-
opment)-425 guidelines. The extract was suspended using
Tween-80 (0.1%) and was administered orally at doses in
the range of 50e2000 mg/kg. The concentration was
adjusted in such a way that it did not exceed 1 mL/kg body
weight of the rats. LD50 was calculated, and three different
doses of MO (150, 350, and 500 mg/kg) were selected for
the evaluation of the antiulcer activity.
2.4. Evaluation of the antiulcer activity using the
pylorus ligation-induced ulcer model
Thirty male Wistar rats were divided into five different
groups with six rats in each group (n Z 6) [1,15]. Pylorus
ligation was performed in all groups of rats for the induc-
tion of gastric ulcers, which was followed by the respective
treatments. Group 1 (control) received normal saline
(0.9%), Group 2 was treated with a standard drug (omep-
razole, 30 mg/kg), and Groups 3, 4, and 5 were treated with
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treatments were given orally to the pylorus-ligated rats.
MaleWistar rats were deprived of food for 18 hours before
pyloric ligation, but had free access to water. Under light
ether anesthesia, the abdomen was opened by using a small
incision below the xiphoid process. The pyloric position of the
stomach was slightly lifted and ligated to avoid traction into
the pylorus or damage to its blood supply. The stomachs were
removed, and the contents were drained into tubes and
centrifuged at 1000 rpm for 10 minutes. Supernatants were
subjected to analysis for gastric volume, pH, free acidity, and
total acidity. The stomachs were then cut along the greater
curvature, the inner surface was examined for ulceration,
and the ulcer index (UI) was calculated [16e18].
2.5. Evaluation of the antiulcer activity using the
ethanol-induced ulcer model
Intragastric application of absolute ethanol is a reproducible
method to produce gastric lesions in experimental animals
[1,15]. The animalswere divided into different groups similar
to the groups used for the pylorus-ligated ulcer model. All
treatments were given orally to the rats. The rats were
deprived of food for 18 hours before the experiment, but had
freeaccess towater. Rats received the treatments 30minutes
before the administration of 1 mL of absolute ethanol. One
hour after the administration of ethanol, the rats were
sacrificed by overdosing with diethyl ether. The stomachs
were excised and gently rinsed with saline (0.9%), inflated
with 1% formalin solution (10 mL), and immersed in the same
solution to fix the outer layer of the stomach. After 10 min,
each stomach was then opened along the greater curvature
and examined under a dissecting microscope to assess the
formation of ulcers [19].
2.6. Measurement of the UI
The opened stomach was examined for ulceration and was
given a scoring number [18]. Ulcer scores were estimated
by viewing the ulcers with a magnifying glass and are as
follows: 0, no ulcer; 1, superficial mucosal erosion; 2, deep
ulcer; 3, perforated or penetrated ulcer. The UI was
determined by using a measuring scale to measure the ul-
cerated area. The ulcerated area and the total mucosal
area were calculated, and the UI was determined as
UIZ10=X;
where X is the ratio of the total mucosal area to the ul-
cerated area. The percentage protection was calculated
using the formula
% ulcer protectionZfðUI of control  UI of testÞ
 100g=UI of control
2.7. Biochemical parameters used to investigate
gastric juice
Gastric juice was collected from pylorus-ligated rats [20].
The volume and the pH of the gastric juice were measured.
For the determinations of the free and the total acidities inthe gastric juice, 1 mL of gastric juice was pipetted into a
100-mL conical flask, and two to three drops of Topfer’s
reagent were added and titrated with 0.01N NaOH until all
traces of red color had disappeared and the solution had
become yellowish orange.
2.8. Statistical analysis
All the values are expressed as mean  SEM (n Z 6). The
data of all groups were analyzed using a one-way analysis of
variance (ANOVA), followed by the Dunnett’s t-test. The
criterion for statistical significance was p < 0.05.
3. Results
Preliminary phytochemical studies revealed the presence
of alkaloids, carbohydrates, proteins, tannins, phenols,
saponins, triterpinoids, and steroids in MO. The MO was
found to be nontoxic when administered orally to the albino
rats at doses in the range of 50e2000 mg/kg, and the LD50
was found to be safe at the highest dose.
The rats treated with MO had significantly (p < 0.01)
reduced ulcer indices compared to the saline-treated py-
lorus-ligated rats (Fig. 1). The percentages of ulcer pro-
tection at doses of 150, 350, and 500 mg/kg were 82.58%,
85.13%, and 86.15%, respectively. Compared to the control
group, the MO-treated group showed an increased gastric
pH and reduced free acidity and total acidity (Table 1). For
rats with ulceration induced using absolute ethanol (1 mL/
kg), the use of MO significantly (p < 0.01) reduced the UI
(Fig. 2), and the percentages of ulcer protection at doses of
150, 350, and 500 mg/kg were 55.75%, 59.33%, and 78.51%,
respectively (Table 2).
4. Discussion
Gastric hyperacidity and ulcers are very common nowa-
days, causing tremendous human suffering [21]. Although
many products are available for the treatment of gastric
ulcers (e.g., antacids and antihistaminics), most of those
drugs produce several adverse reactions, such as arrhyth-
mias, impotence, gynecomastia, and hematopoeitic
changes [22]. The extracts of many herbal plants have been
shown to produce promising results for the treatment of
gastric ulcers with fewer or negligible side effects [23].
Almost all parts of the M. oleifera plant are reported to
have medicinal values for the treatment of various ail-
ments, such as gastrointestinal disorders, tumors, diabetes,
hypertension, renal disorders, bacterial and fungal dis-
eases, and fever [6e11]. Furthermore, an ethanolic leaf
extract of M. oleifera is reported to have potential for the
treatment of gastric lesions [12, 24]. In view of this, the
present study was performed to investigate the antiulcer
potential of the ethanolic root-bark extract of M. oleifera
by using two experimental models in experimental rats:
ethanol-induced gastric lesions and pylorus ligation-
induced gastric ulcers.
An acute oral toxicity study of the MO did not produce
any sign of mortality or toxicity in the rats during the
experiment. The LD50 was found to be safe at the doses
Figure 1 Antiulcer effect of different doses of Moringa oleifera (MO) and omeprazole (30 mg/kg) on pylorus ligation-induced
gastric ulceration in rats.
Table 1 Antiulcer effect of omeprazole and Moringa oleifera (MO) on pylorus ligation-induced ulcers in rats.
Groups Ulcer index (UI) % Protection Free acidity Total acidity pH
Control (saline water) 4.91  0.11 d 56.00  2.70 85.00  2.51 1.25  0.02
Omeprazole (30 mg/kg) 0.42  0.05* 91.44% 2.00  0.40* 16.20  1.02* 2.74  0.09*
MO (150 mg/kg) 0.85  0.11y 82.58% 16.40  1.34y 39.80  1.62y 1.79  0.04y
MO (350 mg/kg) 0.73  0.03* 85.13% 12.20  1.12* 32.80  1.51* 1.91  0.04*
MO (500 mg/kg) 0.68  0.01* 86.15% 6.40  0.96* 23.00  0.72* 2.21  0.07*
Values are expressed as mean  SEM (n Z 6).
*p < 0.01 and yp < 0.05 as compared to control (saline-treated) group (one-way ANOVA followed by Dunnett’s test). Percentage is
calculated as compared to control group.
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Figure 2 Antiulcer effect of different doses of Moringa oleifera (MO) on ethanol-induced gastric ulceration in rats.
218 M.K. Choudhary et al.used in this study. A doseeresponse antiulcer study was
made using 150, 350, and 500 mg/kg of MO for both anti-
ulcer screening models. The pylorus ligation-induced ulcer
model is a simple, reproducible, and highly predictable
model for the screening of antiulcer drugs. It neither uti-
lizes exogenous ulcerogens nor is induced by exogenous
interfering factors. Ulcers are believed to develop because
of an excess of acid and pepsin for a given degree of
mucosal defense [25,26]. Pylorus ligation-induced ulcers
may be attributable to autodigestion of gastric juice,
decreased mucosal blood flow, and breakdown of the
mucosal barrier [27]. In our study, pylorus ligation producedTable 2 Antiulcer effect of omeprazole and Moringa
oleifera (MO) on alcohol-induced ulcers in rats.
Groups Ulcer index (UI) % Protection
Control (saline, 0.9%) 3.92  0.11 d
Omeprazole (30 mg/kg) 0.44  0.03* 88.47%
MO (150 mg/kg) 1.73  0.14y 55.75%
MO (350 mg/kg) 1.59  0.15* 59.33%
MO (500 mg/kg) 0.84  0.16* 78.51%
Values are expressed as mean  SEM (n Z 6).
*p < 0.01 and yp < 0.05 as compared to control group (one-way
ANOVA followed by Dunnett’s test). Percentage is calculated as
compared to control group.a marked increase in gastric lesions and damaged the
stomach mucosal layer in the experimental rats. The
stomachs of rats in the control group (saline treated)
showed higher inductions of gastric ulcers due to increased
levels of gastric juice in the rat’s stomachs; the values of
the pH for the gastric contents were decreased. Group 2
(omeprazole treated, 30 mg/kg) showed significant
(p < 0.01) protection (91.44 %) against gastric ulceration
caused by pylorus ligation compared to the ulcers produced
in the control group. The MO treatment (Groups 3e5) at
different doses (350 and 500 mg/kg) also showed significant
(p < 0.01) decreases in the UI as compared to the control
group, but the effect of the dose of 150 mg/kg was found to
be less significant (p < 0.05) (Fig. 1).
The gastric content of the incised stomachs were
analyzed for the gastric pH, free acidity, and total acidity.
The free acidity and the total acidity were significantly
decreased (p < 0.01), and the pH value of the gastric
content was significantly increased (p < 0.01) by oral
administration of omeprazole (30 mg/kg) and MO (350 and
500 mg/kg) as compared to pylorus-ligated control group,
but administration of MO at 150 mg/kg showed a less
significant result (p < 0.05). These findings indicate that
the MO is effective in reducing gastric ulcers produced by
hyperacidity in the stomach. Even the low dose (150 mg/
kg) has shown sufficient cytoprotective action against
pylorus ligation-induced gastric ulcers and mucosal dam-
age. The agents that decrease gastric acid secretion or
Antiulcer potential of Moringa oleifera extract 219increase mucus secretion are effective in protecting
against ulcers induced by using these methods. The MO
reduced in gastric acid secretion, proving its antisecretory
effect [24].
The absolute ethanol method of inducing gastric lesions
is a rapid and convenient way of screening herbal extracts
for antiulcer activity and cytoprotection in macroscopically
and microscopically visible lesions [28]. The incidence of
ethanol-induced ulcers is predominant in the glandular part
of the stomach and has been reported to stimulate the
formation of leukotriens C4, mast-cell secretory products,
and reactive oxygen species, resulting in damage to the
gastric mucosal layers [29,30]. The formation of gastric
mucosal lesions following ethanol administration involves
several mechanisms, such as a reduction in gastric blood
flow, solubilization of mucus constituents, induction of
oxidative stress, an increase in xanthine oxidase activity,
and increase in malondialdehyde levels, and a decrease in
total glutathione content [31,32]. Ethanol has also been
reported to cause gastric mucosal lesions through vaso-
constriction, the release of vasoactive substances such as
histamine, and the production of free radicals that cause a
discontinuity in the mucosal cell membrane. The high
production of free radicals is another factor associated with
gastric injury and is due to increased lipid peroxidation and
damage to the gastric surface. Accumulation of activated
neutrophils in the gastric mucosa may be a source of this
free radical generation [31]. Free radical scavengers pro-
tect the gastric mucosa against alcohol-induced gastric ul-
ceration [32].
In our experiment, the oral administration of absolute
ethanol (1 mL) to the rats produced gastric ulcers and
mucosal layer damage in the stomachs of the rats. The UI
and the mucosal layer damage were significantly decreased
in the omeprazole (30 mg/kg)-treated group as compared
to the control group (p < 0.01). The MO at different doses
decreased the UI significantly (p < 0.01), but the group that
was administered a dose of 150 mg/kg showed a less sig-
nificant result than the control group (p < 0.05). The results
indicated that all selected doses showed reductions in the
UI, but the dose of 500 mg/kg showed the highest protec-
tion against gastric lesions. The mechanisms involved in the
reduction of ulcers caused by administration of ethanol
may be regeneration of the glandular epithelium, formation
of collagen, increased capillary density, increased pH, and
increased free-radical scavenging action [24].
The qualitative phytochemical analysis of the MO
showed the presence of alkaloids, carbohydrates, proteins,
saponins, tannins, triterpinoids, and steroids. Moringine
and moringinine are the alkaloids found in the root-bark
extract that are useful for treating ulcers. Pterygospermin
is a powerful antibiotic found in M. oleifera and is effec-
tive against a broad range of bacteria, (e.g., H. pylori).
Saponins are widely distributed in plants and are a
particular form of glycoside. Plant materials with antiulcer
activity often contain triterpenoids and saponins in
considerable amounts. The protective activities of these
active saponins are probably due to the activation of mu-
cous membrane protective factors [33]. Tannins are used
in medicine primarily because of their astringent proper-
ties, which are attributable to the fact that they react with
the proteins in the layers of tissue with which they comeinto contact. Tannins are known to “tan” the outermost
layer of the mucosa and to render it less permeable and
more resistant to chemical and mechanical injury or irri-
tation [34].
5. Conclusion
On the basis of the present study, we conclude that MO has
the potential to cure gastric ulcers and gastric mucosal
lesions. It also decreases the acidity and increases the pH of
gastric juice. These findings indicate that MO possesses
antiulcer and antisecretory activity and, hence, can be
used as a source for antiulcer drugs in future. Further
experimental work is ongoing to isolate and identify the
active principles present in the extract that are responsible
for the antiulcer activity.
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